SARM1 and myeloid sarcoma: In summary, our findings reveal an unrecognized function of removal of astrocytic SARM1 to prevent axonal injury, demyelination and neuroinflammation, and reveal its possible regulatory pathways, which will help to develop new therapies for MS.